Document is current
Any future updates will be listed below
-
Authors
Kurotori, Michiko
Nakazawa, Daigo
Watanabe-Kusunoki, Kanako
Hattanda, Fumihiko
Nishio, Saori
Maoka, Tomochika
Yamada, Kanji
Yamamoto, Junya
Yotsukura, Akihiko
Shimazaki, Masaru
Haneda, Tsutomu
Amasaki, Yoshiharu
Fukuzawa, Jun
Endo, Toko
Kato, Akiko
Kudo, Risshi
Yasuda, Takuji
Ebata, Shinichi
Matsuhashi, Naoki
Fukazawa, Sawako
Ishida, Hirohide
Matsuura, Yoshinori
Hioka, Takaya
Ito, Yoichi M.
Takahata, Masahiko
Shimizu, Tomohiro
Atsumi, Tatsuya
- License Information
-
More Information
Article History
Received: 29 January 2026
Accepted: 3 April 2026
First Online: 22 April 2026
Declarations
:
: This study was registered with the Japan Registry of Clinical Trials (jRCTs011230047 -2) prior to participant enrollment. The study protocol has been approved by the Ethics Review Board of Hokkaido University Hospital (CRB no. 1180001; approval no. 022–007), and the current version is 2.2 (approved on 13 February 2025). The study will be carried out according to the principles of the Declaration of Helsinki and its amendments. The researchers will explain this study carefully to the candidates, confirm their understanding, and obtain their written informed consent prior to participation.
: Not required.
: Tomohiro Shimizu has received compensation from Asahi Kasei Pharma Corporation.
